Patients in the Veritac-2 study were randomized to receive a standard estrogen blocker called fulvestrant, or Arvinas' ...

Rocket Lab caught the falling booster of its Electron rocket on Monday with a Sikorsky S-92 helicopter before dropping it in the Pacific Ocean. The crew was forced to let it go for safety reasons.

The Chart of the Day belongs to the aerospace & defense company Rocket Labs (RKLB). I found the stock by using Barchart's powerful screening functions to find stocks with the highest technical buy ...

Rocket Lab stock is up 5.5% through 10:10 a.m. ET Monday morning in response to the news.

Rocket Lab's Electron launch vehicle has established itself as a market leader, achieving a remarkable 100% mission success rate in 2024 and consistently demonstrating high launch frequency and rapid ...

Space company Rocket Lab USA (NASDAQ: RKLB) enjoyed a modest stock price bump in early trading on the Nasdaq Tuesday, rising 3.7% through 10 a.m. ET. The curious thing is that this bump came after ...

Investors looking for stocks that could make dramatic moves in a short, defined time frame will want to turn their attention toward two innovative drugmakers. A couple of stocks in the volatile ...

Saturday's launch was the fourth of five planned missions for Kineis. Rocket Lab stock is up 5.5% through 10:10 a.m. ET Monday morning in response to the news. Mission success for Rocket Lab's ...

If the experimental estrogen degrader delays tumor growth longer than the standard of care, this stock will rocket higher. In a few years, vepdegestrant sales could soar past $1 billion annually ...